Estrogen administration negatively alters mood following monoaminergic depletion and psychosocial stress in postmenopausal women

Neuropsychopharmacology

Volumn 33, Issue 7, 2008, Pages 1514-1527

  Newhouse, Paul A ^a   Dumas, Julie ^a   Hancur Bucci, Catherine ^a   Naylor, Magdalena ^a   Sites, Cynthia K ^b   Benkelfat, Chawki ^c   Young, Simon N ^c  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Estrogen; Menopause; Monoamines; Mood; Stress

Indexed keywords

AMINO ACID MIXTURE; DOPAMINE; ESTRADIOL; MONOAMINE; PHENYLALANINE; PLACEBO; SEROTONIN; SEX HORMONE; TRYPTOPHAN; TYROSINE;

ADULT; AGED; AMINO ACID DEFICIENCY; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINE METABOLISM; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; EMOTIONAL STABILITY; EMOTIONAL STRESS; EMOTIONALITY; ESTROGEN ACTIVITY; ESTROGEN THERAPY; EXERCISE TEST; FEMALE; HUMAN; MENTAL STRESS; MONOAMINE METABOLISM; MOOD CHANGE; NEUROTRANSMISSION; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; SEROTONIN RELEASE; SIDE EFFECT; TEST MEAL; TRIER SOCIAL STRESS TEST;

AFFECT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOGENIC MONOAMINES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ESTRADIOL; ESTROGENS; FEMALE; FOOD, FORMULATED; HUMANS; IMMUNOASSAY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PAIN MEASUREMENT; POSTMENOPAUSE; PSYCHIATRIC STATUS RATING SCALES; STRESS, PSYCHOLOGICAL;

EID: 43649107019     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301530     Document Type: Article

References (90)

1. Amin Z, Epperson CN, Constable RT, Canli T (2006a). Effects of estrogen variation on neural correlates of emotional response inhibition. Neuroimage 32: 457-464.
2. Amin Z, Gueorguieva R, Cappiello A, Czarkowski KA, Stiklus S, Anderson GM et al (2006b). Estradiol and tryptophan depletion interact to modulate cognition in menopausal women. Neuropsychopharmacology 31: 2489-2497.
3. Baumann G (1983). Estrogens and the hypothalamo-pituitary-adrenal axis in man: evidence for normal feedback regulation by corticosteroids. J Clin Endocrinol Metab 57: 1193-1197.
4. Bebbington PE, Dunn G, Jenkins R, Lewis G, Brugha T, Farrell M et al (1998). The influence of age and sex on the prevalence of depressive conditions: report from the national survey of psychiatric morbidity. Psychol Med 28: 9-19.
5. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961). An inventory for measuring depression. Arch Gen Psychiatry 4: 53-63.
6. Best N, Rees MP, Barlow DH, Cowen PJ (1992). Effect of estradiol implant on noradrenergic function and mood in menopausal subjects. Psychoneuroendocrinology 17: 87-93.
7. Bethea CL, Mirkes SJ, Lu NZ, Streicher JM, Cameron JL (2003). Differences in central serotonergic activity in stress-sensitive vs stress-resilient monkeys: tryptophan hydroxylase (TPH), serotonin reuptake transporter (SERT) and serotonin 1A autoreceptor (5HT1A) mRNA expression. The Society of Biological Psychiatry 2003, Annual Meeting. San Francisco, CA, p 558.
8. Beyenburg S, Stoffel-Wagner B, Bauer J, Watzka M, Blumcke I, Bidlingmaier F et al (2001). Neuroactive steroids and seizure susceptibility. Epilepsy Res 44: 141-153.
9. Björn I, Sunderstrom-Poromaa I, Bixo M, Nyberg S, Backstrom G, Backstrom T (2003). Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy. J Clin Endocrinol Metab 88: 2026-2030.
10. Britton KT, Koob GF (1998). Premenstrual steroids? Nature 392: 869-870.
11. Burleson MH, Malarkey WB, Cacioppo JT, Poehlmann KM, Kiecolt-Glaser JK, Berntson GG et al (1998). Postmenopausal hormone replacement: effects on autonomic, neuroendocrine, and immune reactivity to brief psychological stressors. Psychosom Med 60: 17-25.
12. Carey MP, Deterd CH, de Koning J, Helmerhorst F, de Kloet ER (1995). The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat. J Endocrinol 144: 311-321.
13. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301: 386-389.
14. Ceresini G, Freddi M, Morganti S, Rebecchi I, Modena AB, Rinaldi M et al (2000). The effects of transdermal estradiol on the response to mental stress in postmenopausal women: a randomized trial. Am J Med 109: 463-468.
15. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL (2006). Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 63: 385-390.
16. Cummings JA, Brizendine L (2002). Comparison of physical and emotional side effects of progesterone or medroxyprogesterone in early postmenopausal women. Menopause 9: 253-263.
17. Delgado P (2006). Monoamine depletion studies: implications for antidepressant discontinuation syndrome. J Clin Psychiatry 67(Suppl 4): 22-26.
18. Dennerstein L, Lehert P, Burger HG, Guthrie JR (2007). New findings from non-linear longitudinal modeling of menopausal hormone changes. Hum Reprod Update: doi:10.1093/humupd/dmm022.
19. Ellenbogen MA, Young SN, Dean P, Palmour RM, Benkelfat C (1996). Mood response to acute tryptophan depletion in healthy volunteers: sex differences and temporal stability. Neuropsychopharmacology 15: 465-474.
20. Ellenbogen MA, Young SN, Dean P, Palmour RM, Benkelfat C (1999). Acute tryptophan depletion in healthy young women with a family history of major affective disorder. Psychol Med 29: 35-46.
21. Fink G, Sumner BEH, Rosie R, Grace O, Quinn JP (1996). Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol 16: 325-344.
22. First MB, Spitzer RL, Gibbon M, Williams JBW (2001). Structured Clinical Interview for DSM-IV-TR Axis I Disorders-Patient Edition, SCID-I/P, 21/2001 edn. American Psychiatric Press Inc: Washington, DC.
23. Folstein MF, Folstein SE, McHugh PR (1975). 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
24. Freeman EW, Sammel MD, Lin H, Nelson DB (2006). Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 63: 375-382.
25. Goldfien A, Monroe S (1983). The Ovaries. In: Greenspan F, Forsham P (eds). Basic and Clinical Endocrinology. Lange: Los Altos, CA, pp 368-413.
26. Goldstein JM, Jerram M, Poldrack R, Ahern T, Kennedy DN, Seidman LJ et al (2005a). Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J Neurosci 25: 9309-9316.
27. Goldstein KM, Harpole LH, Stechuchak KM, Coffman CJ, Bosworth HB, Steffens DC et al (2005b). Hormone therapy does not affect depression severity in older women. Am J Geriatr Psychiatry 13: 616-623.
28. Golightly KL, Lloyd JA, Hobson JE, Gallagher P, Mercer G, Young AH (2001). Acute tryptophan depletion in schizophrenia. Psychol Med 31: 75-84.
29. Grigoriadis S, Kennedy SH (2002). Role of estrogen in the treatment of depression. Am J Ther 9: 503-509.
30. Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K (1995). Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 37: 434-441.
31. Harrison BJ, Olver JS, Norman TR, Burrows GD, Wesnes KA, Pradeep NJ (2004). Selective effects of acute serotonin and catecholamine depletion on memory in healthy women. Int J Neuropsychopharmacol 18: 32-40.
32. Hays J, Ockene JK, Brunner R, Kotchen JM, Manson JE, Patterson RE et al (2003). Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 348: 1839-1854.
33. Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA, for the HRG (2002). Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the heart and estrogen/progestin replacement study (HERS) trial. JAMA 287: 591-597.
34. Jurica PJ, Leitten CL, Mattis S (2001). Dementia Rating Scale-2. Psychological Assessment Resources Inc.: Lutz, FL.
35. Kajantie E, Phillips DIW (2006). The effects of sex and hormonal status on the physiological response to acute psychosocial stress. Psychoneuroendocrinology 31: 151.
36. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S et al (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 51: 8-19.
37. Kirschbaum C, Pirke KM, Hellhammer DH (1993). The 'Trier Social Stress Test' - a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28: 76-81.
38. Kirschbaum C, Prussner JC, Stone AA, Federenko I, Gaab J, Lintz D et al (1995). Persistent high cortisol responses to repeated psychological stress in a subpopulation of healthy men. Psychosom Med 57: 468-474.
39. Komesaroff PA, Esler MD, Sudhir K (1999). Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J Clin Endocrinol Metab 84: 606-610.
40. Kudielka BM, Schmidt-Reinwald AK, Hellhammer DH, Kirschbaum C (1999). Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment. Neuroendocrinology 70: 422-430.
41. Kugaya A, Epperson CN, Zoghbi S, van Dyck CH, Hou Y, Fujita M et al (2003). Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry 160: 1522-1524.
42. Leyton M, Young SN, Pihl RO, Etezadi S, Lauze C, Blier P et al (1999). Effects on mood of acute phenylalanine/tyrosine depletion in healthy women. Neuropsychopharmacology 22: 52-63.
43. Lindheim SR, Legro RS, Bernstein L, Stanczyk FZ, Vijod MA, Presser SC et al (1992a). Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. American Journal of Obstetrics and Gynecology 167: 1831-1836.
44. Lindheim SR, Legro RS, Bernstein L, Stanczyk FZ, Vijod MA, Presser SC et al (1992b). Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. Am J Obstet Gynecol 167: 1831-1836.
45. Lindheim SR, Legro RS, Morris RS, Wong IL, Tran DQ, Vijod MA et al (1994). The effect of progestins on behavioral stress responses in postmenopausal women. J Social Gynecol Invest 1: 79-83.
46. Magiakou MA, Mastorakos G, Webster E, Chrousos GP (1997). The hypothalamic-pituitary-adrenal axis and the female reproductive system. Ann NY Acad Sci 816: 42-56.
47. Majewska MD (1992). Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol 38: 379-395.
48. Matthews KA, Owens JF, Salomon K, Harris KF, Berga SL (2005). Influence of hormone therapy on the cardiovascular responses to stress of postmenopausal women. Biol Psychol 69: 39.
49. McDermott JL, Kreutzberg JD, Liu B, Dluzen DE (1994). Effects of estrogen treatment on sensorimotor task performance and brain dopamine concentrations in gonadectomized male and female CD-1 mice. Horm Behav 28: 16-28.
50. McEwen B (2002). Estrogen actions throughout the brain. Recent Prog Horm Res 57: 357-384.
51. McNair DM, Lorr M, Droppleman LF (1971). Profile of Mood States. Educational and Industrial Testing Service: San Diego, CA.
52. Milenkoviæ L, Bogiæ L, Martinoviæ JV (1986). Effect of oestradiol and progesterone on stress-induced secretion of prolactin in ovarectomized and/or adrenalectomized female rats. Acta Endocrinol 112: 79-82.
53. Miller KJ, Conney JC, Rasgon NL, Fairbanks LA, Small GW (2002). Mood symptoms and cognitive performance in women estrogen users and nonusers and men. J Am Geriatr Soc 50: 1826-1830.
54. Morrison MF, Kallan MJ, Ten Have T, Katz I, Tweedy K, Battistini M (2004). Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry 55: 406-412.
55. Nagata H, Nozaki M, Nakano H (2005). Short-term combinational therapy of low-dose estrogen with selective serotonin re-uptake inhibitor (fluvoxamine) for oophorectomized women with hot flashes and depressive tendencies. J Obstet Gynaecol Res 31: 107-114.
56. Overall J, Gorham D (1993). The brief psychiatric rating scale. Psychol Rep 10: 799-812.
57. Palinkas LA, Barrett-Connor E (1992). Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol 80: 30-36.
58. Pearson R, Lewis MB (2005). Fear recognition across the menstrual cycle. Horm Behav 47: 267-271.
59. Porter RJ, Phipps AJ, Gallagher P, Scott A, Stevenson PS, O'Brien JT (2005). Effects of acute tryptophan depletion on mood and cognitive functioning in older recovered depressed subjects. Am J Geriatr Psychiatry 13: 607-615.
60. Prior JC (1998). Perimenopause: the complex endocrinology of the menopausal transition. Endocr Rev 19: 397-428.
61. Protopopescu X, Pan H, Altemus M, Tuescher O, Polanecsky M, McEwen B et al (2005). Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle. Proc Natl Acad Sci USA 102: 16060-16065.
62. Rasgon NL, Altshuler LL, Fairbanks LA, Dunkin JJ, Davtyan C, Elman S et al (2002). Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women. J Clin Psychiatry 63: 42-48.
63. Rasgon NL, Dunkin J, Fairbanks L, Altshuler LL, Troung C, Elman S et al (2007). Estrogen and response to sertraline in postmenopausal women with major depressive disorder: a pilot study. J Psychiatr Res 41: 338-343.
64. Reisberg B, Ferris SH, de Leon MJ, Crook T (1993a). The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 139: 1136-1139.
65. Reisberg B, Ferris S (1988). Brief Cognitive Rating Scale (BCRS). Psychopharmacol Bull 24: 629-636.
66. Resnick SM, Coker LH, Maki PM, Rapp PR, Espeland MA, Shumaker SA (2004). The women's health initiative study of cognitive aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clin Trials 1: 440-450.
67. Resnick SM, Maki PM, Rapp SR, Espeland MA, Brunner R, Coker LH et al (2006). Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab 91: 1802-1810.
68. Rohleder N, Schommer NC, Hellhammer DH, Engel R, Kirschbaum C (2001). Sex differences in glucocorticoid sensitivity of proinflammatory cytokine production after psychosocial stress. Psychosom Med 63: 966-972.
69. Roy BN, Reid RL, Van Vugt DA (1999). The effects of estrogen and progesterone on corticotropic-releasing hormone and arginine vasopressin messenger ribonucleic acid levels in paraventricular nucleus and supraoptic nucleus of the rhesus monkey. Endocrinology 140: 2191-2196.
70. Rubinow D, Schmidt P, Roca C (1993). Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry 44: 839-850.
71. Saab PG, Matthews KA, Stoney CM, McDonald RH (1989). Premenopausal and postmenopausal women differ in their cardiovascular and neuroendocrine responses to behavioral stressors. Psychophysiology 26: 270-280.
72. Schleifer LA, Justice AJ, de Wit H (2002). Lack of effects of acute estradiol on mood in postmenopausal women. Pharmacol, Biochem Behav 71: 71-77.
73. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH et al (2000). Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 183: 414-420.
74. Schneider LS, Small GW, Hamilton SH, Bystritsky A, Nemeroff CB, Meyers BS (1993). Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Am J Geriatr Psychiatry 5: 97-106.
75. Shansky RM, Glavis-Bloom C, Lerman D, McRae P, Benson C, Miller K et al (2004). Estrogen mediates sex differences in stress-induced prefrontal cortex dysfunction. Molecular Psychiatry 9: 531-538.
76. Sherwin BB (1991). The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 72: 336-343.
77. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS et al (2004). Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. J Am Med Assoc 291: 2947-2957.
78. Smith SS, Gong QH, Hsu FC, Markowitz RS, ffrench-Mullen JM, Li X (1993). GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392: 926-930.
79. Soares CN, Poitras JR, Prouty J (2003a). Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause. Drugs Aging 20: 85-100.
80. Soares CN, Poitras JR, Prouty J, Alexander AB, Shifren JL, Cohen LS (2003b). Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms. J Clin Psychiatry 64: 473-479.
81. Steiner M, Dunn E, Born L (2003). Hormones and mood: from menarche to menopause and beyond. J Affect Disord 74: 67-83.
82. Stoppe G, Doren M (2002). Critical appraisal of effects of estrogen replacement therapy on symptoms of depressed mood. Arch Women's Ment Health 5: 39-47.
83. Vamvakopoulos NC, Chrousos GP (1993). Evidence of direct estrogenic regulation of human corticotropic-releasing hormone gene expression. J Clin Invest 92: 1896-1902.
84. Voss S, Quail D, Dawson A, Backstrom T, Aguas F, Erenus M et al (2002). A randomised, double-blind trial comparing raloxifene HCl and continuous combined hormone replacement therapy in postmenopausal women: effects on compliance and quality of life. BJOG: Int J Obstet Gynaecol 109: 874-885.
85. Weissman M, Myers J (1993). Depression in the elderly: research directions in psychopathology, epidemiology, and treatment. J Geriatr Psychiatry 12: 187-201.
86. Whooley MA, Grady D, Cauley JA (2000). Postmenopausal estrogen therapy and depressive symptoms in older women. J Gen Intern Med 15: 535-541.
87. Wood GE, Shors TJ (1998). Stress facilitates classical conditioning in males, but impairs classical conditioning in females through activational effects of ovarian hormones. Proc Natl Acad Sci 95: 4066-4071.
88. Young S, Leyton M (1993). The role of serotonin in human mood and social interaction: insight from altered tryptophan levels. Pharmacol Biochem Behav 71: 857-865.
89. Young SN, Smith SE, Pihl RO, Ervin FR (1993). Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 87: 173-177.
90. Zweifel JE, O'Brien WH (1997). A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 22: 189-212.